drug

ensifentrine

1 story · latest Jul 7, 2026

Status: FDA approved Jun 2024 · NDA217389
Brand: Ohtuvayre

Relationships

Developed by Merck & Co., Inc.

Timeline

Vor Biopharma board sees director change as Levin resigns, Zaccardelli named

Jul 7PeopleVor Biopharma

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.